Sphera Funds Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Sphera Funds Management’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-43,695	Closed	-$605K	–	187
2014 Q4	$605K	Hold	43,695	–	–	0.1%	119
2014 Q3	$542K	Sell	43,695 -1,305	-3%	-$18K	0.07%	118
2014 Q2	$821K	Hold	45,000	–	–	0.2%	82
2014 Q1	$976K	Sell	45,000 -3,125	-6%	-$90.5K	0.22%	93
2013 Q4	$1.7M	Buy	+48,125	New	+$1.61M	0.47%	55

Other funds holding KBIO

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OPPM

Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

OWIM

Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sphera Funds Management's KBIO Position: Q1 2015 in Review

Sphera Funds Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 43,695 shares — an estimated $605K sold.

Sphera Funds Management first reported a position in KBIO in Q4 2013 and held it in 5 quarters. The position peaked at $1.7M in Q4 2013. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

Sphera Funds Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
Sphera Funds Management sold 43,695 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $605K.
Sphera Funds Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q4 2013 and held it in 5 quarters.
Sphera Funds Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $1.7M in Q4 2013.
24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on Sphera Funds Management's 13F filing for Q1 2015, filed 11 May 2015.